Schizophrenia
15 competing products in clinical development for Schizophrenia.
Pipeline by Phase
Pre-clinical1
Phase 14
Phase 23
Phase 31
Approved6
All Products (15)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Olanzapine + Aripiprazole | Eli Lilly | Approved | Completed | 43 |
| olanzapine therapy | Eli Lilly | Approved | Completed | 43 |
| Clozapine + Olanzapine | Eli Lilly | Approved | Completed | 43 |
| Atomoxetine | Eli Lilly | Approved | Completed | 43 |
| Olanzapine + olanzapine + risperidone | Eli Lilly | Approved | Completed | 43 |
| Olanzapine + Placebo | Eli Lilly | Phase 3 | Completed | 40 |
| olanzapine-RAIM + placebo | Eli Lilly | Phase 2 | Completed | 35 |
| Risperidone + Placebo + LY2140023 | Eli Lilly | Phase 2 | Completed | 35 |
| Zotepine + Risperidone | Astellas Pharma | Approved | Terminated | 35 |
| ASP4345 + placebo + risperidone + quetiapine + olanzapine + ziprasidone + aripiprazole + brexpiprazole + paliperidone + lurasidone | Astellas Pharma | Phase 2 | Completed | 35 |
| ASP4345 + Matching Placebo | Astellas Pharma | Phase 1 | Completed | 29 |
| ASP6981 + Placebo | Astellas Pharma | Phase 1 | Completed | 29 |
| SAPHRIS + Asenapine | Sun Pharmaceutical | Phase 1 | Completed | 29 |
| Torrent's Quetiapine Fumarate Tablets | Torrent Pharmaceuticals | Phase 1 | Completed | 29 |
| antipsychotic dose increase | Eli Lilly | Pre-clinical | Completed | 26 |